MedPath

Effect of repetitive transcranial magnetic stimulation in children with generalised dystonia

Phase 3
Conditions
Health Condition 1: G249- Dystonia, unspecified
Registration Number
CTRI/2022/01/039806
Lead Sponsor
Child Neurology Division
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children with age between 5 to 18 years of either sex.

2.Presence of generalized dystonia

3.On stable antidystonic pharmacotherapy and physiotherapy for atleast 3 months

4. BFMDRS-M score of 52 or more

Exclusion Criteria

Primary Exclusion Criteria

1.Children diagnosed with progressive neurometabolic or neurodegenerative disorder on the basis of course of illness, neuroimaging and standard diagnostic evaluation.

2.Children with unilateral dystonia

3.Children with uncontrolled epilepsy defined as 4 or more seizures in last 6 months

4.Children with metallic implants anywhere in the body.

5.Children who underwent DBS/ pallidotomy.

6.Parents refusing consent for enrolment in the study.

Secondary Exclusion Criteria (to be applied at the end of observation phase I)

1.Change in antidystonia, antipsychotic or antiseizure medications during the observation period

2.Occurrence of seizure during the observation period

3.Repeat BFMDRS-M score after 4 week observation <52

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath